Contact Us

HOTEL NEWS

EpiVax Drives Immunogenicity Innovation in 2024: Year in Review

Dec 10, 2024

PROVIDENCE,R.I.,Dec. 7,2024--EpiVax,Inc.,a leader in preclinical immunogenicity risk assessment for biologic and peptide therapeutics,celebrates a productive 2024 marked by scientific innovation,serv

GCCAC advances cooperation with BRI partners

Dec 10, 2024

FUZHOU,China,Dec. 7,2024-- The 2024 Belt and Road Commerce Chambers and Associations Conference (GCCAC) was held in Fuzhou,East China\'s Fujian Province on Thursday.

Caliway Biopharmaceuticals Included in FTSE TWSE Taiwan Eight Industries and Mid-Cap 100 Indices

Dec 10, 2024

NEW TAIPEI CITY,Dec. 7,2024-- Caliway Biopharmaceuticals Co.,Ltd. (TWSE-6919) is proud to announce its inclusion in the FTSE TWSE Taiwan Mid-Cap 100 Index and the FTSE TWSE Taiwan Eight Industries In

Gift Cards Take Center Stage This Christmas: Australian Shoppers to Spend Nearly Half of Gift Budget on Flexible Presents

Dec 10, 2024

MELBOURNE,Australia,Dec. 9,2024-- According to new research[1]from global branded payment provider,Blackhawk Network (BHN),Aussie consumers plan to allocate nearly half (44%) of their total gift spend

Innovent Presents Updated Data From Innovative Anti-CLDN18.2 ADC (IBI343) Phase 1 Study in Patients with Advanced Pancreatic Cancer at the ESMO Asia Congress 2024

Dec 10, 2024

SAN FRANCISCO and SUZHOU,China,Dec. 9,2024-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high-qua

Gentari to supply large-scale, carbon-free energy to AMG Ammonia

Dec 10, 2024

650 MW firm dispatchable RE supply to power AMG Ammonia\'s upcoming green ammonia facilities. ~2,400 MWp RE capacity to be set up,making it the single largest greenfield project by Gentari globally.

1 ... 173 174 175 176 177 178 179 ... 351